Drägerwerk AG & Co. KGaA (LON: 0MT8)
London
· Delayed Price · Currency is GBP · Price in EUR
48.00
+0.40 (0.84%)
Jan 23, 2025, 12:18 PM BST
Drägerwerk AG & Co. KGaA Revenue
Drägerwerk AG & Co. KGaA had revenue of 774.57M EUR in the quarter ending September 30, 2024, a decrease of -1.77%. This brings the company's revenue in the last twelve months to 3.35B, up 0.26% year-over-year. In the year 2023, Drägerwerk AG & Co. KGaA had annual revenue of 3.37B with 10.78% growth.
Revenue (ttm)
3.35B EUR
Revenue Growth
+0.26%
P/S Ratio
n/a
Revenue / Employee
205.01K EUR
Employees
16,329
Market Cap
822.49M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.37B | 328.28M | 10.78% |
Dec 31, 2022 | 3.05B | -283.19M | -8.51% |
Dec 31, 2021 | 3.33B | -77.86M | -2.29% |
Dec 31, 2020 | 3.41B | 625.45M | 22.49% |
Dec 31, 2019 | 2.78B | 185.81M | 7.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |